Hypoxia Pathway Proteins are Master Regulators of Erythropoiesis
Erythropoiesis is a complex process driving the production of red blood cells. During homeostasis, adult erythropoiesis takes place in the bone marrow and is tightly controlled by erythropoietin (EPO), a central hormone mainly produced in renal EPO-producing cells. The expression of EPO is strictly...
Main Authors: | Deepika Watts, Diana Gaete, Diego Rodriguez, David Hoogewijs, Martina Rauner, Sundary Sormendi, Ben Wielockx |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/21/8131 |
Similar Items
-
Hypoxia Pathway Proteins and Their Impact on the Blood Vasculature
by: Diego Rodriguez, et al.
Published: (2021-08-01) -
HIF-Prolyl Hydroxylase Domain Proteins (PHDs) in Cancer—Potential Targets for Anti-Tumor Therapy?
by: Diana Gaete, et al.
Published: (2021-02-01) -
Hypoxia Pathway Proteins As Central Mediators of Metabolism in the Tumor Cells and Their Microenvironment
by: Sundary Sormendi, et al.
Published: (2018-01-01) -
Regulation of erythropoiesis: emerging concepts and therapeutic implications
by: Pu Tang, et al.
Published: (2023-12-01) -
Erythropoietin and a hypoxia‐inducible factor prolyl hydroxylase inhibitor (HIF‐PHDi) lowers FGF23 in a model of chronic kidney disease (CKD)
by: Megan L. Noonan, et al.
Published: (2020-06-01)